C. Otigbah et al., IS HTLV-1 STATUS ANOTHER ANTENATAL SCREENING-TEST THAT WE NEED, British journal of obstetrics and gynaecology, 104(2), 1997, pp. 258-260
Human T-lymphocytic virus type 1 (HTLV-1) carriage is associated with
a 2% to 5% lifetime risk of developing a severe, if not fatal, disease
. In our Inner London antenatal population, we found that the carrier
rate was 0.3%. The antenatal transmission rate is known to be very low
, but if the infant is breastfed the transmission rate is up to 25%. I
t is therefore possible to interrupt the transmission cycle by advisin
g against breastfeeding. The ethical and fiscal issues surrounding ant
enatal testing are addressed.